A Pilot Study of Dynamic Magnetic Resonance Dacryocystography Imaging to Assess Functional Epiphora
CONCLUSION: MRDCG shows a high rate of block in functional epiphora. However, DSG and MRDCG results may not always correlate. The improved temporal resolution of this emerging modality may be advantageous in the critical first 2 min of tear transit.PMID:37697818 | DOI:10.1080/08820538.2023.2256842 (Source: Seminars in Ophthalmology)
Source: Seminars in Ophthalmology - September 12, 2023 Category: Opthalmology Authors: Carmelo Zak Macri Yinon Shapira Jessica Tong Kylie Hood Peter Drivas Sandy Patel Dinesh Selva Source Type: research
The Top 100 Most-Cited Articles on Thyroid Eye Disease: A Bibliometric Study
CONCLUSION: A variety of medical disciplines, Western countries, and study personnel contributed to highly cited thyroid eye disease research. Thus, this research area is not exceedingly informed by any singular perspective. Further, it can be interpreted with increased confidence for their generalizability of results to patients globally.PMID:37695018 | DOI:10.1080/08820538.2023.2256838 (Source: Seminars in Ophthalmology)
Source: Seminars in Ophthalmology - September 11, 2023 Category: Opthalmology Authors: Brendan Tao Jonathan Micieli Source Type: research
Report of Two Cases of Ocular Monkeypox
Semin Ophthalmol. 2023 Sep 6:1-4. doi: 10.1080/08820538.2023.2253893. Online ahead of print.NO ABSTRACTPMID:37671883 | DOI:10.1080/08820538.2023.2253893 (Source: Seminars in Ophthalmology)
Source: Seminars in Ophthalmology - September 6, 2023 Category: Opthalmology Authors: Nicholas Cuppari Megh Shah Mohammad Dastjerdi Source Type: research
Network Meta-Analysis of Different Thrombolytic Strategies for the Treatment of Central Retinal Artery Occlusion
CONCLUSION: Both intravenous and intra-arterial thrombolytic strategies are effective for treating CRAO, but SUCRA results show that IVtPA may be the optimal strategy for treating CRAO. Furthermore, based on the results of subgroup analysis, we further speculate that IVtPA injection within 4.5 hours of the onset of CRAO should be the optimal thrombolytic option for treating CRAO. However, due to the limitations of all eligible studies, more studies are still required in the future to validate our findings.PMID:37644706 | DOI:10.1080/08820538.2023.2249539 (Source: Seminars in Ophthalmology)
Source: Seminars in Ophthalmology - August 30, 2023 Category: Opthalmology Authors: Yong Liu Shanshan Cao Yanyan Zhao Tengyun Wu Quan Wang Source Type: research
